rs114276563

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015702.3(MMADHC):​c.473G>A​(p.Arg158Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,601,534 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0056 ( 11 hom., cov: 33)
Exomes 𝑓: 0.00065 ( 9 hom. )

Consequence

MMADHC
NM_015702.3 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.966

Publications

2 publications found
Variant links:
Genes affected
MMADHC (HGNC:25221): (metabolism of cobalamin associated D) This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
MMADHC Gene-Disease associations (from GenCC):
  • inborn disorder of cobalamin metabolism and transport
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • methylmalonic aciduria and homocystinuria type cblD
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007001728).
BP6
Variant 2-149576442-C-T is Benign according to our data. Variant chr2-149576442-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377064.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00558 (850/152210) while in subpopulation AFR AF = 0.0194 (804/41526). AF 95% confidence interval is 0.0183. There are 11 homozygotes in GnomAd4. There are 403 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMADHCNM_015702.3 linkc.473G>A p.Arg158Gln missense_variant Exon 5 of 8 ENST00000303319.10 NP_056517.1 Q9H3L0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMADHCENST00000303319.10 linkc.473G>A p.Arg158Gln missense_variant Exon 5 of 8 1 NM_015702.3 ENSP00000301920.5 Q9H3L0
MMADHCENST00000422782.2 linkc.473G>A p.Arg158Gln missense_variant Exon 5 of 9 5 ENSP00000408331.2 F8WEC0
MMADHCENST00000428879.5 linkc.473G>A p.Arg158Gln missense_variant Exon 4 of 7 2 ENSP00000389060.1 Q9H3L0

Frequencies

GnomAD3 genomes
AF:
0.00556
AC:
846
AN:
152092
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00152
AC:
382
AN:
251312
AF XY:
0.00105
show subpopulations
Gnomad AFR exome
AF:
0.0204
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.000651
AC:
943
AN:
1449324
Hom.:
9
Cov.:
27
AF XY:
0.000567
AC XY:
409
AN XY:
721866
show subpopulations
African (AFR)
AF:
0.0229
AC:
764
AN:
33294
American (AMR)
AF:
0.00110
AC:
49
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26050
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39562
South Asian (SAS)
AF:
0.0000814
AC:
7
AN:
85968
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.000871
AC:
5
AN:
5740
European-Non Finnish (NFE)
AF:
0.0000336
AC:
37
AN:
1100652
Other (OTH)
AF:
0.00135
AC:
81
AN:
59948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00558
AC:
850
AN:
152210
Hom.:
11
Cov.:
33
AF XY:
0.00542
AC XY:
403
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0194
AC:
804
AN:
41526
American (AMR)
AF:
0.00235
AC:
36
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
67992
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
40
80
119
159
199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00212
Hom.:
2
Bravo
AF:
0.00660
ESP6500AA
AF:
0.0170
AC:
75
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00182
AC:
221
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Methylmalonic aciduria and homocystinuria type cblD Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 13, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Disorders of Intracellular Cobalamin Metabolism Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.39
T;T;T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.033
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.93
.;D;D
MetaRNN
Benign
0.0070
T;T;T
MetaSVM
Uncertain
-0.28
T
MutationAssessor
Benign
2.0
M;M;.
PhyloP100
0.97
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.5
N;N;N
REVEL
Benign
0.27
Sift
Benign
0.039
D;D;D
Sift4G
Benign
0.11
T;T;T
Polyphen
0.0080
B;B;B
Vest4
0.20
MVP
0.70
MPC
0.037
ClinPred
0.010
T
GERP RS
3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.15
gMVP
0.31
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114276563; hg19: chr2-150432956; COSMIC: COSV57574201; API